Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GoodRx

Take a Mid-Year Review of Your Health Insurance Coverage

Whether it's monitoring your deductible or using a health savings account, here are the best ways to maximize use of your health insurance coverage

Kiplinger

3 Top Stocks Under $10 to Buy Instead of GameStop

Meme stocks such as GME and AMC have risen substantially this month. However, due to their weak fundamentals, these companies are high-risk investments.

Barchart

Sempre Health's innovative approach improves medication adherence and lowers costs

Initiatives like GoodRx and Sempre Health are working towards transparency and affordability in the drug supply chain to improve medication adherence. Blue...

Top News

From analysis to the latest developments in health,
read the most diverse news in one place.

Flovent — a common asthma inhaler — will be discontinued in 2024. There will be a generic version available, but the change could make it hard for some patients to get their medication.

WEKU

Walgreens Launches Digital Tool To Help Save On Prescription Costs

Walgreens says its Rx Savings Finder will help customers compare coupon prices to get the best deal.

Kiplinger

Free prescription discount cards from GoodRx — What’s the catch?

GoodRx’s prescription savings program offers significant discounts on prescription drugs, but not without some catches

The Independent UK

3 Hot Stocks Under $10 for Your September Watchlist

These outperformers are all trading under $10 per share - for now. After beating the S&P 500 year-to-date, analysts think these standout single-digit stocks all have room to keep running higher.

Barchart

Read news from The Economist, FT, and more,
with one subscription

A fertility app with lots of leaks

The agency says the fertility app Premom deceived users about their data.

Fortune

Mark Cuban has been taking on the drug industry. But which one?

The billionaire entrepreneur is making waves with his new drug company. But his generics aren’t always the lowest-priced deal.

Fortune

Editorial: FTC crackdown on GoodRx sends a message that private consumer data must be protected

Since 2017, GoodRx has helped millions of people find deals on prescription drugs via an app and website. But what its customers may not have known is that the Santa Monica-based health company had also been sharing information about their prescriptions and illnesses with third parties such as Google and…

Los Angeles Times

FTC fines GoodRx for unauthorized sharing of health data

The Federal Trade Commission has imposed a $1.5 million penalty on telehealth and prescription drug discount provider GoodRx Holdings Inc. for sharing users’ personal health data with Facebook, Google and other third parties without their consent

The Independent UK

Discount prescription company GoodRx fined $1.5 million for sharing sensitive user info

The FTC alleged the company shared info on users’ medication and illnesses for the purpose of targeted ads.

Chicago Sun-Times

Wegovy works. But here's what happens if you can't afford to keep taking the drug

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

WEKU

Climate change magnifies health impacts of wildfire smoke in care deserts

DRESSLERVILLE, Nev. — Smoke began billowing into the skies of northwestern Nevada in September, clouding the mountains, dimming the sun — and quashing residents’ hopes that they would be spared from wildfires and the awful air quality the blazes produce.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

5 things to know about the FDA's flawed approach to accelerated drug approvals

An NPR investigation found stalled confirmatory trials and lax enforcement are plaguing the FDA's accelerated approval of drugs for urgent medical needs.

WEKU

Drugmakers are slow to prove medicines that got a fast track to market really work

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Benzinga

Baird Maintains Neutral Rating for GoodRx Holdings: Here's What You Need To Know

Baird has decided to maintain its Neutral rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $7.00 to $6.00. Shares of GoodRx Holdings are trading up 6.94% over the last 24 hours, at $6.32 per share. A move to $6.00 would account for a 5.06% decline from the…

Benzinga

Goldman Sachs Maintains Buy Rating for GoodRx Holdings: Here's What You Need To Know

Goldman Sachs has decided to maintain its Buy rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $30.00 to $12.00. Shares of GoodRx Holdings are trading up 1.32% over the last 24 hours, at $8.07 per share.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

GoodRx Shares Tumble As FY22 Guidance Hit By Grocery Chain Prescription Dispute

GoodRx Holdings Inc (NASDAQ: GDRX) shares fell after it expects FY22 revenue to take a hit due to recent actions by one grocery store chain that represents a sizable chunk of its grocery prescription business.

The Independent UK

Can billionaire celebrity Mark Cuban fix America’s broken health system?

The celebrity investor has teamed up with a soft-spoken radiologist to tackle the USA’s healthcare crisis – and he has drug industry middlemen squarely in his sights, reports Io Dodds

Tribune News Service

¿Enfrentando la inflación? Expertos ofrecen consejos conforme a la edad

Un día de este mes, Olivia Jurkovich pagó 53 dólares por llenar parcialmente su tanque de gasolina. Eso es 20 dólares más de lo que normalmente paga para llenar su Mazda SUV.

Tribune News Service

Trying to fight inflation? Experts offer age-based tips

Olivia Jurkovich paid $53 for a partial tank of gas one day this month. That's $20 more than what she normally pays to top off her Mazda SUV.

StockNews.com

3 Healthtech Stocks Wall Street Predicts Will Rally More Than 40% or More: GoodRx, 23andMe, and Exact Sciences

The COVID-19 pandemic has accelerated digital adoption in healthcare. And because this trend is attracting massive investments into digital health care, Wall Street analysts expect popular health tech stocks Exact Sciences Corp (EXAS), GoodRx Holdings (GDRX), 23andMe (ME) to rally in price soon. Read on.

Benzinga

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

TherapeuticsMD Inc (NASDAQ:TXMD) has agreed to divest its VitaCare Prescription Services business to GoodRx Holdings Inc (NASDAQ:GDRX) for $150 million. VitaCare is a consumer-focused digital healthcare platform. TherapeuticsMD will also receive an additional $7 million in cash consideration contingent upon vitaCare's financial performance through 2023. TXMD will also enter into a long-term services agreement to…

Benzinga

GoodRx Plunges As Q4 Fall Short Of Expectations, Analysts Cut Price Target

Consumer-focused digital healthcare, GoodRx Holdings Inc (NASDAQ: GDRX) shares are plunging after the company's

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.